Arrowhead Pharmaceuticals Inc (ARWR)
18.54
+0.26
(+1.42%)
USD |
NASDAQ |
Nov 22, 16:00
18.53
-0.01
(-0.05%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Shareholders Equity (Quarterly): 330.55M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 330.55M |
March 31, 2024 | 483.79M |
December 31, 2023 | 160.41M |
September 30, 2023 | 271.34M |
June 30, 2023 | 364.83M |
March 31, 2023 | 446.77M |
December 31, 2022 | 377.04M |
September 30, 2022 | 398.52M |
June 30, 2022 | 453.93M |
March 31, 2022 | 452.27M |
December 31, 2021 | 372.56M |
September 30, 2021 | 408.82M |
June 30, 2021 | 436.89M |
March 31, 2021 | 445.55M |
December 31, 2020 | 454.47M |
September 30, 2020 | 461.78M |
June 30, 2020 | 493.14M |
March 31, 2020 | 494.12M |
December 31, 2019 | 500.08M |
September 30, 2019 | 244.59M |
June 30, 2019 | 226.23M |
March 31, 2019 | 201.20M |
December 31, 2018 | 172.06M |
September 30, 2018 | 95.80M |
June 30, 2018 | 102.31M |
Date | Value |
---|---|
March 31, 2018 | 114.27M |
December 31, 2017 | 70.75M |
September 30, 2017 | 81.42M |
June 30, 2017 | 90.10M |
March 31, 2017 | 93.89M |
December 31, 2016 | 97.76M |
September 30, 2016 | 95.58M |
June 30, 2016 | 59.98M |
March 31, 2016 | 74.48M |
December 31, 2015 | 92.92M |
September 30, 2015 | 110.18M |
June 30, 2015 | 131.30M |
March 31, 2015 | 144.75M |
December 31, 2014 | 146.26M |
September 30, 2014 | 166.54M |
June 30, 2014 | 186.36M |
March 31, 2014 | 191.40M |
December 31, 2013 | 82.73M |
September 30, 2013 | 27.50M |
June 30, 2013 | 34.96M |
March 31, 2013 | 5.313M |
December 31, 2012 | 8.975M |
September 30, 2012 | 10.01M |
June 30, 2012 | 9.365M |
March 31, 2012 | 12.24M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
160.41M
Minimum
Dec 2023
500.08M
Maximum
Dec 2019
410.89M
Average
445.55M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
Vaxcyte Inc | 3.418B |
CEL-SCI Corp | 8.473M |
AIM ImmunoTech Inc | 2.912M |
IGC Pharma Inc | 7.377M |
NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 883.76M |
Total Liabilities (Quarterly) | 544.78M |